Global drug pricing: How cost-effective is bevacizumab?
Global drug pricing: How cost-effective is bevacizumab?
Update on olaparib in ovarian cancer
CPX-351 improves outcomes for refractory AML
Radiotherapy modalities for locally advanced non-small cell lung cancer
First in-human trials of rovalpituzumab for SCLC
Impact of precision medicine in refractory malignancies
Large disparities found in BCRA testing across ethnicities
Surgery in stage 4 breast cancer increased survival
Trial shows exercise beneficial for patients undergoing chemotherapy
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours
ASCO 2016: Plenary Session Review